Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ, Proceedings of the Nutrition Society, vol.93, issue.03, pp.329-339, 2001. ,
DOI : 10.1038/29795
Endocannabinoids and the control of energy balance, Trends in Endocrinology & Metabolism, vol.18, issue.1, pp.27-37, 2007. ,
DOI : 10.1016/j.tem.2006.11.006
Endocannabinoid control of food intake and energy balance, Nature Neuroscience, vol.284, issue.5, pp.585-589, 2005. ,
DOI : 10.1074/jbc.M211248200
Leptin-regulated endocannabinoids are involved in maintaining food intake, Nature, vol.410, issue.6830, pp.822-825, 2001. ,
DOI : 10.1038/35071088
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats, British Journal of Pharmacology, vol.143, issue.6, pp.1151-1154, 2001. ,
DOI : 10.1038/sj.bjp.0704379
Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors, Psychopharmacology, vol.143, issue.3, pp.315-317, 1999. ,
DOI : 10.1007/s002130050953
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats, Hepatology, vol.330, issue.1, pp.122-129, 2007. ,
DOI : 10.1002/hep.21641
The anti-obesity effect of rimonabant is associated with an improved serum lipid profile, Diabetes, Obesity and Metabolism, vol.103, issue.1, pp.65-72, 2005. ,
DOI : 10.1074/jbc.M209033200
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice, American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, vol.284, issue.2, pp.345-353, 2003. ,
DOI : 10.1152/ajpregu.00545.2002
Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia, New England Journal of Medicine, vol.353, issue.20, pp.2121-2134, 2005. ,
DOI : 10.1056/NEJMoa044537
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, The Lancet, vol.365, issue.9468, pp.1389-1397, 2005. ,
DOI : 10.1016/S0140-6736(05)66374-X
The endocannabinoid system: Body weight and metabolic regulation, Clinical Cornerstone, vol.8, pp.24-35, 2006. ,
DOI : 10.1016/S1098-3597(06)80041-4
Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats, Diabetes, vol.57, issue.11, pp.2977-2991, 2008. ,
DOI : 10.2337/db08-0161
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice, Journal of Clinical Investigation, vol.118, issue.9, pp.3160-3169, 2008. ,
DOI : 10.1172/JCI34827
The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells, Molecular Pharmacology, vol.63, issue.4, pp.908-914, 2003. ,
DOI : 10.1124/mol.63.4.908
Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets, Molecular and Cellular Endocrinology, vol.286, issue.1-2, pp.66-78, 2008. ,
DOI : 10.1016/j.mce.2008.01.026
URL : https://hal.archives-ouvertes.fr/hal-00531993
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men, Int J Obes (Lond), vol.31, pp.692-699, 2007. ,
Changes in plasma endocannabinoid levels in viscerally obese men following a 1??year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors, Diabetologia, vol.35, issue.2, pp.213-217, 2009. ,
DOI : 10.1007/s00125-008-1178-6
Beneficial effect of a chronic treatment with rimonabant on pancreatic function and ??-cell morphology in Zucker Fatty rats, European Journal of Pharmacology, vol.616, issue.1-3, pp.314-320, 2009. ,
DOI : 10.1016/j.ejphar.2009.05.024
The CB1 Antagonist Rimonabant Decreases Insulin Hypersecretion in Rat Pancreatic Islets, Obesity, vol.291, issue.Suppl 1, pp.1856-1860, 2009. ,
DOI : 10.1038/oby.2009.234
Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice, International Journal of Obesity, vol.29, issue.2, pp.183-187, 2005. ,
DOI : 10.1038/sj.ijo.0802847
Obesity-associated improvements in metabolic profile through expansion of adipose tissue, Journal of Clinical Investigation, vol.117, issue.9, pp.2621-2637, 2007. ,
DOI : 10.1172/JCI31021DS1
Hepatic steatosis is not due to impaired fatty acid oxidation capacities in C57BL/6J mice fed the conjugated trans-10,cis-12-isomer of linoleic acid, J Nutr, vol.134, pp.861-867, 2004. ,
A simple method for the isolation and purification of total lipides from animal tissues, J Biol Chem, vol.226, pp.497-509, 1957. ,
Liver Carbohydrate and Lipid Metabolism of Insulin-Deficient Mice Is Altered by trans-10, cis-12 Conjugated Linoleic Acid, Journal of Nutrition, vol.139, issue.10, 2009. ,
DOI : 10.3945/jn.109.111062
Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation, Diabetologia, vol.42, issue.Suppl 2, pp.1380-1386, 2006. ,
DOI : 10.1007/s00125-006-0244-1
Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid, The Journal of Lipid Research, vol.47, issue.12, pp.2647-2655, 2006. ,
DOI : 10.1194/jlr.M600140-JLR200
The role of the endocannabinoid system in lipogenesis and fatty acid metabolism, Best Practice & Research Clinical Endocrinology & Metabolism, vol.23, issue.1, pp.51-63, 2009. ,
DOI : 10.1016/j.beem.2008.10.002
CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity, International Journal of Obesity, vol.28, issue.4, pp.640-648, 2004. ,
DOI : 10.1038/sj.ijo.0802583
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity, Journal of Clinical Investigation, vol.115, issue.5, pp.1298-1305, 2005. ,
DOI : 10.1172/JCI200523057
Inhibition of Rat-Liver Acetyl-Coenzyme-A Carboxylase by Palmitoyl-Coenzyme A. Formation of Equimolar Enzyme-Inhibitor Complex, European Journal of Biochemistry, vol.73, issue.1, pp.33-41, 1978. ,
DOI : 10.1016/0003-2697(73)90217-0
Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients, JAMA, vol.295, issue.7, pp.761-775, 2006. ,
DOI : 10.1001/jama.295.7.761
Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor-Deficient Mouse, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.3, pp.721-727, 2000. ,
DOI : 10.1161/01.ATV.20.3.721
Scavenger Receptor BI-mediated Selective Uptake Is Required for the Remodeling of High Density Lipoprotein by Endothelial Lipase, Journal of Biological Chemistry, vol.284, issue.10, pp.6093-6100, 2009. ,
DOI : 10.1074/jbc.M807683200
Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity, Diabetes, vol.55, issue.11, pp.3053-3060, 2006. ,
DOI : 10.2337/db06-0812
Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and ??-Pancreatic Cells and in Obesity and Hyperglycemia, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.8, pp.3171-3180, 2006. ,
DOI : 10.1210/jc.2005-2679
Endocannabinoid Dysregulation in the Pancreas and Adipose Tissue of Mice Fed With a High-fat Diet, Obesity, vol.15, issue.3, pp.553-565, 2008. ,
DOI : 10.1038/oby.2007.106
APRIL 2010 expression of adipogenic genes is decreased in obesity and diabetes mellitus, diabetesjournals.org DIABETES Proc Natl Acad Sci, vol.5997, pp.11371-11376, 2000. ,
Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus, International Journal of Obesity, vol.28, pp.12-21, 2004. ,
DOI : 10.1038/sj.ijo.0802853
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance, The FASEB Journal, vol.19, pp.1567-1569, 2005. ,
DOI : 10.1096/fj.04-3177fje
Insulin resistance in type 2 diabetes: role of fatty acids, Diabetes/Metabolism Research and Reviews, vol.16, issue.S2, pp.5-9, 2002. ,
DOI : 10.1002/dmrr.254
Immune-mediated Activation of the Endocannabinoid System in Visceral Adipose Tissue in Obesity, Hormone and Metabolic Research, vol.39, issue.8, pp.596-600, 2007. ,
DOI : 10.1055/s-2007-984459
The endogenous cannabinoid system protects against colonic inflammation, Journal of Clinical Investigation, vol.113, issue.8, pp.1202-1209, 2004. ,
DOI : 10.1172/JCI200419465
Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-??, Cytokine & Growth Factor Reviews, vol.14, issue.5, pp.447-455, 2003. ,
DOI : 10.1016/S1359-6101(03)00052-2
The Role of Adipocyte Insulin Resistance in the Pathogenesis of Obesity-Related Elevations in Endocannabinoids, Diabetes, vol.57, issue.5, pp.1262-1268, 2008. ,
DOI : 10.2337/db07-1186
Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding, British Journal of Pharmacology, vol.354, issue.2, pp.451-461, 2009. ,
DOI : 10.1111/j.1476-5381.2009.00183.x
The Endogenous Cannabinoid System Stimulates Glucose Uptake in Human Fat Cells via Phosphatidylinositol 3-Kinase and Calcium-Dependent Mechanisms, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.12, pp.4810-4819, 2007. ,
DOI : 10.1210/jc.2007-0768
Adipokines: molecular links between obesity and atheroslcerosis, AJP: Heart and Circulatory Physiology, vol.288, issue.5, pp.2031-2041, 2005. ,
DOI : 10.1152/ajpheart.01058.2004
The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.1302, issue.2, pp.93-109, 1996. ,
DOI : 10.1016/0005-2760(96)00066-5
Adiponectin gene activation by thiazolidinediones requires PPAR??2, but not C/EBP?????evidence for differential regulation of the aP2 and adiponectin genes, Biochemical and Biophysical Research Communications, vol.308, issue.4, pp.933-939, 2003. ,
DOI : 10.1016/S0006-291X(03)01518-3